StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Merck (MRK) PT Lowered to $129 at Goldman Sachs
February 5, 2025 6:35 AM
Goldman Sachs analyst Chris Shibutani lowered the price target on Merck (NYSE: MRK) to $129.00 (from $135.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Merck (MRK) PT Lowered to $97 at Wells Fargo
February 5, 2025 6:21 AM
Merck Canada urges Canadians to take action for their lung health with new “Listen Close” campaign
February 4, 2025 11:15 AM
CIBC Launches 10 New U.S. Market CDRs on Cboe Canada
February 4, 2025 10:00 AM
Merck Canada urges Canadians to take action for their lung health with new “Listen Close” campaign
February 4, 2025 8:00 AM
Merck shares tumble on Q4 earnings miss, weak 2025 guidance
February 4, 2025 6:57 AM
Form 8-K Merck & Co., Inc. For: Feb 04
February 4, 2025 6:46 AM
Merck stops Gardasil shipments to China, hitting 2025 outlook; shares tumble
February 4, 2025 6:32 AM
Merck (MRK) Misses Q4 EPS by 9c; misses on outlook
February 4, 2025 6:31 AM
Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results
February 4, 2025 6:30 AM
Merck (MRK) call put ratio 3.1 calls to 1 put with a focus on February 7 weekly 100 calls
February 3, 2025 10:37 AM
